Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $22.7000 (-2.11%) ($22.6800 - $23.2500) on Thu. Jan. 23, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.75% (three month average) | RSI | 31 | Latest Price | $22.7000(-2.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.8% a day on average for past five trading days. | Weekly Trend | IOVA declines -5.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) ARKG(48%) XBI(48%) IWO(44%) ARKK(43%) | Factors Impacting IOVA price | IOVA will decline at least -1.875% in a week (0% probabilities). VIXM(-29%) VXX(-16%) UUP(-10%) TLT(-2%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.875% (StdDev 3.75%) | Hourly BBV | 0 () | Intraday Trend | -1.8% | | | |
|
1 - 5 Day Possible Target | $10.46(-53.92%) | Resistance Level | $25.71 | 5 Day Moving Average | $23.44(-3.16%) | 10 Day Moving Average | $24.34(-6.74%) | 20 Day Moving Average | $25.71(-11.71%) | To recent high | -22.8% | To recent low | 12.2% | Market Cap | $3.324b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |